Enfusion rose over 20% after it opened at $20 above $17 IPO price

Tiger Newspress2021-10-21

Enfusion rose over 20% after itopened at $20 above $17 IPO price.​Enfusion is a global fast-growing SaaS provider, focusing on the transformation of the investment management industry. The company aims to remove technical and information barriers and enable investment managers to confidently make and execute smarter investment decisions in real time. In 2019-2020, the company's revenues were US $59.03 million and US $79.57 million respectively, and the corresponding net profits were US $12.66 million and US $4.06 million respectively.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

发表看法
122